Phone: +47 32 79 88 00
Fax: +47 32 79 88 01
Bente Falang, CEO
Phone: +47 40403495
PreTect AS is a Norwegian research-based company that develops and manufactures high quality in vitro diagnostic (IVD) reagents. All research, development and manufacturing are performed in-house at our HQ in Norway.
As company, we have a clear focus to improve early detection of cervical disease and prevent cervical cancer with our HPV mRNA products. We carefully focus on the needs of patients and users, by continued innovation and application of new technology.
PreTect AS has several valid patents within the field of HPV mRNA detection and prevention of cervical cancer in Europe and US. Our vision “PreTect shall give all people a better daily life through development, production and marketing of products for efficient and safe diagnostics and treatment“ is achieved through fulfilment of all applicable laws, regulations and the NS-EN ISO 13485 standard.
PreTect AS was founded in 1998 under the company name NorChip AS. NorChip AS launched in 2003 the worlds first test for oncogenic activity in cervical samples. In January 2015 the company name changed to PreTect AS.
PreTect AS is a wholly owned subsidiary of Gentian Diagnostics AS
PreTect AS certified according to ISO 9001 and ISO 13485.